European stocks and Dow futures rise after Trump’s push on coronavirus treatments

angel may

FDA Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment, during a press conference at the White House on August 23, 2020, in Washington, D.C. Pete Marovich/Getty Images European stocks rose […]

FDA Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment, during a press conference at the White House on August 23, 2020, in Washington, D.C.


Pete Marovich/Getty Images

European stocks rose on Monday, as drug stocks climbed after President Donald Trump signaled an aggressive stance to push COVID-19 medical treatments to return the economy closer to normalcy.

After slipping 0.8% last week, the Stoxx Europe 600
SXXP,
+1.57%

jumped 1.4%.

The French CAC 40
PX1,
+2.27%

rose 2.2%, the German DAX
DAX,
+2.36%

topped 13,000, and the U.K. FTSE 100
UKX,
+1.71%

also gained ground.

Futures on the Dow Jones Industrial Average
YM00,
+0.96%

rose 216 points.

After Trump accused the Food and Drug Administration of trying to sabotage his re-election efforts, the FDA gave emergency approval for the use of blood plasma from recovered coronavirus patients, which hasn’t been proved by scientific trials. The Financial Times said Trump may order the FDA to grant approval to the University of Oxford vaccine to be distributed by AstraZeneca by the same manner.

AstraZeneca
AZN,
+2.06%

AZN,
+1.97%

shares rose 2.9%.

“The drug in question still has a long way to go in terms of development, but the bulls have jumped on the story. Keep in mind that stocks were coming from a low base as markets fell on Friday on the back of the largely disappointing manufacturing and services data from France and Germany,” said David Madden, market analyst at CMC Markets U.K.

While there is no major economic report due for release on Monday, attention is building to the annual Jackson Hole conference, where Federal Reserve Chairman Jerome Powell is expected to outline the central bank’s new inflation strategy. Bank of England Governor Andrew Bailey also will address that conference.

Shares of BT Group
BT.A,
+7.07%

climbed 5%, after Sky News reported the telecoms giant has asked Goldman Sachs to update its defense strategy from possible suitors. BT shares have been hurt after slashing its dividend. BT hasn’t yet received any takeover approaches, the report said.

Shares of Bunzl
BNZL,
+2.57%

rose nearly 4%, as the distribution and outsourcing company reinstated dividends and announced two acquisitions.

Source Article

Next Post

LTC/USD resumes the recovery, bulls target at $70.00

Litecoin has been growing steadily since the weekend.  The next strong bullish target is created by psychological barrier of $70.00. Litecoin (LTC) has gained over 5% in the recent 24 hours to trade at $62.47 by press time. The 7th largest digital asset with the current market capitalization of $4.00 […]